Strengthens presence in the U.S. and international markets with next-generation clinical and deep-tech solutions
Bengaluru, India — November 24, 2025: zMed Healthcare Technologies, a rapidly growing health-technology innovator, today announced the launch of zMed Healthcare Technologies Inc, a new U.S.-based subsidiary established to accelerate its global expansion and deepen its engagement with clients across the United States and other international markets. The launch marks a significant milestone in zMed’s mission to transform healthcare delivery through advanced clinical technologies, AI-driven platforms, and data-intelligence solutions.
Built on the strong foundation of its parent company zMed, the new entity will serve as a strategic hub for global operations, customer success, regulatory alignment, and product innovation tailored for large health systems, clinical research ecosystems, and technology-forward care providers.
Brief history of zMed Healthcare Technologies
Founded with a vision to simplify and modernize clinical operations, zMed Healthcare Technologies quickly emerged as a trusted technology partner for hospitals, diagnostic networks, and care-delivery organizations. The company began with a focus on intelligent workflow systems and later expanded into AI-powered clinical-decision tools, digital diagnostics, and integrated care platforms.
Over the years, zMed Healthcare Technologies has:
- Delivered scalable solutions for care management, operational efficiency, and digital transformation
- Served enterprise healthcare clients across India, the Middle East, and the US
- Built proprietary AI engines that support clinical insights, ICU automation, and real-time care coordination
- Collaborated with clinicians, researchers, and global health consultants to advance patient-centered technology
Today, zMed stands as a comprehensive platform company delivering deep-tech products across critical care, diagnostics, hospital operations, and digital therapeutics—setting the stage for zMed Inc. to expand this innovation footprint globally.
Driving the next phase of global growth
With healthcare organizations worldwide adopting AI-enabled systems, predictive analytics, and real-time clinical insights, zmed.inc is positioned to meet this demand with precision, speed, and reliability.
The creation of the U.S. subsidiary will:
- Strengthen zMed’s direct presence in one of the world’s most advanced healthcare markets
- Enable closer collaboration with healthcare providers, research institutions, and med-tech innovators
- Accelerate regulatory and product compliance, ensuring U.S. and global standards are met
- Increase customer responsiveness, delivering local support, onboarding, and integration services
- Drive co-innovation through partnerships with hospitals, AI labs, and clinical-technology organizations
Key growth priorities
As zMed Inc. becomes operational, the organization has outlined several areas of strategic focus:
1. Scaling Clinical AI Products
zMed’s portfolio of AI-enhanced tools—including ICU automation platforms, early warning systems, and smart triage engines—will be adapted and scaled for U.S. and international clinical environments.
2. Building Interoperability Layers
The U.S. market presents a unique opportunity for zMed to deepen integration with EHR systems, clinical databases, and hospital-information systems to support seamless data flow and improved decision-making.
3. Expanding Research Collaborations
With strong demand for real-world evidence and data-driven health innovation, zMed Inc. will facilitate partnerships with universities, clinical research centers, and innovation accelerators.
4. Enhancing Customer Success Infrastructure
The subsidiary will establish local teams for implementation, support, technical onboarding, and product training—ensuring a high-touch experience for enterprise clients.
5. Investing in Talent and Innovation
zMed Inc. plans to onboard engineering, regulatory, product management, and AI research talent within the U.S., fueling its next stage of deep-tech innovation.
Leadership commentary
“The establishment of zMed Inc. marks a pivotal moment in our global journey. The U.S. market offers immense opportunities for deep-tech healthcare solutions, and we are now strongly positioned to deliver next-generation clinical technologies at scale. This move reinforces our commitment to transforming healthcare ecosystems worldwide,” says Jayakanth Kesan, CEO and Managing Director, zMed.
About zMed Healthcare Technologies
zMed is a healthcare technology company delivering advanced AI-powered platforms, clinical software, and operational intelligence solutions to hospitals and care organizations across the globe. With a strong heritage built through zMed, the company focuses on enabling smarter, safer, and more efficient healthcare delivery.
zMed’s product suite spans ICU automation, digital diagnostics, clinical analytics, workflow orchestration, and predictive-care engines—empowering clinicians with real-time insights and improving patient outcomes at scale.
For more information, visit www.zmed.tech. and www.zmed.inc